5-(Trifluoromethyl)-4-((trimethylsilyl)ethynyl)-1H-pyrrolo[2,3-b]pyridine

Catalog No. :
ACNVPH825
CAS No. :
1261365-60-9
Molecular Formula :
C13H13F3N2Si
Molecular Weight :
282.34

IUPAC Name:5-(trifluoromethyl)-4-((trimethylsilyl)ethynyl)-1H-pyrrolo[2,3-b]pyridine

5-(Trifluoromethyl)-4-((trimethylsilyl)ethynyl)-1H-pyrrolo[2,3-b]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$1086.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(Trifluoromethyl)-4-((trimethylsilyl)ethynyl)-1H-pyrrolo[2,3-b]pyridine
IUPAC Name5-(trifluoromethyl)-4-((trimethylsilyl)ethynyl)-1H-pyrrolo[2,3-b]pyridine
MDL No.MFCD18374151
Molecular FormulaC13H13F3N2Si
Molecular Weight282.34
SMILESC[Si](C#CC1=C2C(NC=C2)=NC=C1C(F)(F)F)(C)C
InChI KeyNWYBHFXLBJIPMT-UHFFFAOYSA-N
Synonym5-(Trifluoromethyl)-4-((trimethylsilyl)ethynyl)-1H-pyrrolo[2,3-b]pyridine | CS-0443951 | trimethyl-[2-[5-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-4-yl]ethynyl]silane | 5-(Trifluoromethyl)-4-[(trimethylsilyl)ethynyl]-1H-pyrrolo[2,3-b]pyridine | 5-(Triflu
CAS No.1261365-60-9
PubChem CID50987485

Safety Data

Pictogram
Toxic
Signal Word
Gefahr
Hazard Statement(s)
H301
Precautionary Statement(s)
P301+P310

Synthetic Route by SureRoute

1. ACNVPH825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNVPH825 route product structure diagram
    ACNVPH8251261365-60-9
Inquiry

2. ACNVPH825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACLSNP526 route compound structure diagram
    ACLSNP5261196507-58-0 In Stock
  4. Then
  5. ACNVPH825 route product structure diagram
    ACNVPH8251261365-60-9
Inquiry

Comments (0)